{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:24:23Z","timestamp":1759091063557},"reference-count":9,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J of Med Genetics Pt A"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec><jats:label \/><jats:p>Siblings presented as neonates with severe jaundice and transfusion\u2010dependent hemolytic anemia. Next\u2010generation sequencing revealed both to have three heterozygous mutations in the gene encoding erythrocyte pyru<jats:bold>v<\/jats:bold>ate kinase (<jats:italic>PKLR<\/jats:italic>), plus a heterozygous splice mutation in the beta\u2010spectrin gene (<jats:italic>SPTB<\/jats:italic>). In addition, both have a different 5th mutation in a gene encoding other erythrocyte membrane proteins. The asymptomatic parents and all three asymptomatic siblings have different sets of these mutations. \u00a9 2016 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ajmg.a.37828","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T05:36:43Z","timestamp":1467178603000},"page":"2449-2452","source":"Crossref","is-referenced-by-count":7,"title":["Siblings with severe pyruvate kinase deficiency and a complex genotype"],"prefix":"10.1002","volume":"170","author":[{"given":"Robert D.","family":"Christensen","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics University of Utah School of Medicine Salt Lake City Utah"},{"name":"Women and Newborns Clinical Program Intermountain Healthcare Salt Lake City Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan M.","family":"Yaish","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics University of Utah School of Medicine Salt Lake City Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto H.","family":"Nussenzveig","sequence":"additional","affiliation":[{"name":"ARUP Laboratories Salt Lake City Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana M.","family":"Agarwal","sequence":"additional","affiliation":[{"name":"ARUP Laboratories Salt Lake City Utah"},{"name":"Department of Pathology University of Utah School of Medicine Salt Lake City Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.05.043"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2014.68"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000438482"},{"key":"e_1_2_6_5_1","first-page":"717","volume-title":"Hereditary spherocytosis, hereditary elliptocytosis, and other disorders associated with abnormalities of the erythrocyte membrane. In Wintrobe's clinical hematology","author":"Gallagher PG","year":"2014"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24088"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2007.05.001"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1182\/blood.V81.8.2155.2155","article-title":"Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40glutamic acid\u2010>lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore)","volume":"81","author":"Rybicki AC","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1182\/blood.V124.21.4007.4007","article-title":"Phase I single (SAD) and multiple ascending dose (MAD) Studies of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of AG\u2010348, a first\u2010in\u2010class allosteric activator of pyruvate kinase\u2010R, in healthy subjects","volume":"124","author":"Yang H","year":"2014","journal-title":"Blood"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2007.01.001"}],"container-title":["American Journal of Medical Genetics Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajmg.a.37828","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajmg.a.37828","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajmg.a.37828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T23:38:59Z","timestamp":1696635539000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajmg.a.37828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1002\/ajmg.a.37828"],"URL":"https:\/\/doi.org\/10.1002\/ajmg.a.37828","archive":["Portico"],"relation":{},"ISSN":["1552-4825","1552-4833"],"issn-type":[{"value":"1552-4825","type":"print"},{"value":"1552-4833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,29]]}}}